Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.47 USD | -0.91% |
|
-1.16% | -20.39% |
06-14 | Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup | DJ |
06-14 | EU regulator mandates label updates on CAR-T cancer therapies | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.39% | 81.06B | |
+51.45% | 791B | |
+40.45% | 630B | |
+17.49% | 328B | |
+9.09% | 298B | |
+17.25% | 246B | |
+0.41% | 225B | |
+10.22% | 218B | |
+4.53% | 160B | |
-5.78% | 156B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences Insider Sold Shares Worth $702,466, According to a Recent SEC Filing